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ABSTRACT The interactions between phospholipid molecules in suspensions have been studied by using mass
spectrometry. Electrospray mass spectra of homogeneous preparations formed from three different phospholipid molecules
demonstrate that under certain conditions interactions between 90 and 100 lipid molecules can be preserved. In the presence of
apolipoprotein C-II, a phospholipid binding protein, a series of lipid molecules and the protein were observed in complexes. The
speciﬁcity of binding was demonstrated by proteolysis; the resulting mass spectra reveal lipid-bound peptides that encompass
the proposed lipid-binding domain. The mass spectra of heterogeneous suspensions and their complexes with apolipoprotein
C-II demonstrate that the protein binds simultaneously to two different phospholipids. Moreover, when apolipoprotein C-II is
added to lipid suspensions formed with local concentrations of the same lipid molecule, the protein is capable of remodeling the
distribution to form one that is closer to a statistical arrangement. These observations demonstrate a capacity for apolipoprotein
C-II to change the topology of the phospholipid surface. More generally, these results highlight the fact that mass spectrometry
can be used to probe lipid interactions in both homogeneous and heterogeneous suspensions and demonstrate reorganization
of the distribution of lipids upon surface binding of apolipoprotein C-II.
INTRODUCTION
Apolipoprotein C-II (apoC-II) is a soluble plasma protein
with a mass of 8915 Da. It is one of a family of apo-
lipoproteins involved in lipid transport and metabolism in
plasma. In vivo it is found predominantly in chylomicrons
and very low density lipoproteins (VLDLs) (Havel et al.,
1973; Jackson and Holdsworth, 1986), where it binds
reversibly to the polar phospholipid surface. It functions as
an activator of lipoprotein lipase (LpL), the enzyme that
hydrolyses triacylglycerols (Havel et al., 1973; Jackson and
Holdsworth, 1986). The binding of apoC-II to the lipid
surface is required to promote a high-afﬁnity complex
between apoC-II and lipoprotein lipase (Clarke and Hol-
brook, 1985). In vitro apoC-II is able to associate with a range
of natural and synthetic lipid surfaces, with a change in
secondary structure. Like other apolipoproteins, apoC-II
associates with lipids via amphipathic helices (Segrest et al.,
1992). In the absence of lipid, the protein shows very little
secondary structure. In the presence of sodium dodecyl
sulfate (SDS) micelles, an NMR structure of apoC-II has
been determined (MacRaild et al., 2001). Three regions of
a-helix were deﬁned (Fig. 1), the largest comprising residues
16–36 and forming the SDS-binding domain (MacPhee et al.,
1999). The hydrophobic face of this helix consists of two
clusters of hydrophobic residues that form a convex face.
The N-terminal 12 residues were found to be disordered and
structurally heterogeneous. Since the chylomicrons are the
largest lipoproteins in plasma, it has been proposed that the
convex binding surface of apoC-II may explain its prefer-
ence for these larger and therefore less curved structures
(MacRaild et al., 2001).
For membrane proteins much progress has been made in
developing sophisticated biophysical approaches (see for
example Arora and Tamm, 2001, and references therein).
Although electrospray mass spectrometry is increasingly
being applied to deﬁne the stoichiometry of proteins in
complex with other proteins, ligands, and cofactors (Last and
Robinson, 1999), investigations involving protein and lipid
interactions are limited. Typically, for electrospray mass
spectrometry, procedures involving concentrated organic
acid are required to extract protein from the membrane in
a soluble form (le Coutre et al., 2000). These methods give
rise to well resolved spectra of the protein but do not provide
information about noncovalent lipid binding interactions.
For transmembrane peptides direct analysis from lipid
suspensions has been used to demonstrate the presence of
residues that are protected from hydrogen exchange with
aqueous solvents (Bouchard et al., 1999; Demmers et al.,
2001, 2000). Of the few examples that have been reported
that examine protein lipid interactions directly by mass
spectrometry, the preferential binding and stability of single
lipid molecules to a protein have been demonstrated (de
Brouwer et al., 2002; Demmers et al., 2003). In this study we
have used mass spectrometry to investigate the interactions
between lipids in both heterogeneous and homogenous
preparations. We also examine the tendency of the same lipid
to associate to form homogeneous suspensions in the
presence of other lipids and the effect on these associations
when complexes are formed with apoC-II.
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MATERIALS AND METHODS
Apolipoprotein C-II
Apolipoprotein C-II was produced as described previously (Hatters et al.,
2000). Brieﬂy, it was expressed in Escherichi coli using the pET11a
expression vector (Novagen, WI). Inclusion bodies were washed and
resuspended in 5 ml of 5 M guanidine HCl, and 100 mM arginine, pH 12.0.
The solution was sonicated for 1 min and centrifuged. The resulting solution
was applied to a gel ﬁltration column and the eluent applied to an anion-
exchange column and eluted using a 0–500-mM NaCl gradient. The protein
was dialysed against 10 mM ammonium bicarbonate, pH 8.0, at 48C,
lyophilized, and stored as a stock solution in 5 M guanidine HCl at 208C.
Phospholipids
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC), and 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoethanolamine (POPE) (Avanti Polar Lipids, AL) have
molecular weights of 678, 760, and 718, respectively. For a 1-mM solution
of DMPC, 7 mg of the dry DMPC powder was suspended in aqueous buffer
(10 ml ammonium acetate, 10 mM, pH 7.0). The resulting suspension was
vortexed vigorously to homogeneity (turbid suspension), sonicated using
a Soniprep sonicator probe (Integrated Services, NJ) for periods of 1 min
with intervals of 1 min on ice, to prevent overheating. After ;15 min the
suspensions became clear. Maximal clarity was achieved after;45 min. For
the mixtures of lipids two different preparations were examined. The ﬁrst
involves dissolution of 1:1 molar ratios of the dry phospholipid powders in
CHCl3, followed by solvent evaporation and resuspension in the aqueous
buffer, according to standard protocols (New, 1990). For the second
approach dry powders were mixed without prior dissolution in organic
solvent and the same procedures as described above for homogeneous
vesicle preparation were employed.
Apolipoprotein C-II with phospholipids
ApoC-II stock solution (29 mg/ml) was diluted to a ﬁnal concentration of 20
mM in 10 mM ammonium acetate, pH 7.0, and 20-ml aliquots were applied
to a Bio-spin 6 size-exclusion chromatography column (Bio-Rad Labora-
tories, CA). A quantity of 41.7 ml of the resulting apoC-II solution was
added to 8.3 ml of the 1 mM phospholipid suspension to give a ﬁnal protein/
lipid concentration ratio of 1:10, in a volume of 50 ml.
For apoC-II with mixed lipid suspensions produced using the ﬁrst
approach, apoC-II stock solution (40 mg/ml) was diluted to a ﬁnal
concentration of 160 mM in 10 mM ammonium acetate, pH 7.0, and 20 ml
was applied to a Bio-spin 6 size-exclusion chromatography column. A
quantity of 5 ml of this solution was added to 5 ml of 10 mM 1:1 molar ratio
lipid suspensions to a 1:63 ﬁnal concentration ratio of protein to lipid. For
apoC-II with mixed lipid suspensions produced using the second approach,
10 mM suspensions of the lipid mixtures were diluted 6.25 times to
a concentration of 1.6 mM. A total of 5 ml of these solutions was mixed with
an equal volume of apoC-II, 160 mM, to a ﬁnal protein/lipid concentration
ratio of 1:10.
Chymotrypsin digestion of apoC-II and apoC-II
DMPC mixtures
A quantity of 2.5 ml of a 1-mg/ml solution of chymotrypsin (;40 mM) at pH
7.5 was added to 47.5ml of either 20 mM apoC-II solution or apoC-II DMPC
solution, such that the chymotrypsin/apoC-II ratio was 2:19 and 2:17,
respectively. The mixtures were incubated on ice for a maximum of 3 h, and
at speciﬁed time points 2-ml aliquots were removed for analysis.
Mass spectrometry
Nanoﬂow capillaries were prepared on a P97 Flaming/Brown micropipette
puller (Sutter Instrument Company, Intracel, Hertfordshire, UK) using
borosilicate glass capillaries of internal diameter 0.5 mm and external
diameter 1.0 mm (Harvard Apparatus, Kent) and gold coated using an SEM
coating system (Polaron, Energy Beam Sciences, MA). A quantity of 2-ml
aliquots of sample were loaded into capillaries, and spectra were recorded on
modiﬁed QToF2 (Sobott et al., 2002) and LCT mass spectrometers
(Micromass UK, Manchester, UK). The capillary and cone voltages were
maintained at 1800 V and 80 V, respectively. Pressure conditions were
maintained in the LCT at 93 103 mbar in the analyser, 1.23 100 mbar for
the backing gas, and 3.23 107 mbar in the ToF, and 43 103 mbar in the
ion guide, 23 105 mbar in the quadrupole analyser, and 53 107 mbar in
the ToF for the QToF. The pressure in the analyser was raised to maintain
a larger number of lipid/lipid and protein/lipid interactions. The highest
analyser pressure used was 53 102 mbar in the QToF2 and 43 100 mbar
in the LCT.
Data analysis
Manipulation and analysis of mass spectra were performed with Masslynx v
3.1 (Micromass UK). The average mass of apoC-II was calculated from at
least three charge states. All spectra were calibrated using 10 mM caesium
iodide and the masses measured are centroided values. The estimated error in
these measurements is calculated from the standard deviation of the charge
states. All mass spectra have undergone minimal smoothing and no
resolution enhancement, and are the average of 10–30 2-s acquisitions.
Charge state series are not a common feature of lipid and protein/lipid
spectra. Rather, there are series of peaks with the same charge but increasing
number of lipid molecules. It is not possible therefore to calculate the mass
of these species using standard mass spectrometry software. To assign the
peaks in the spectra, all possible combinations and charge states of lipid
molecules in complex with one apoC-II molecule were calculated in
Microsoft Excel. These m/z values were compared to those in the mass
spectra. For the analysis of heterogeneous mixtures of phospholipids
theoretical binomial distributions were calculated using Microsoft Excel.
FIGURE 1 Structure of apoC-II derived from NMR experiments
(MacRaild et al., 2001), produced using MolMol (Koradi et al., 1996).
The residues at the N- and C-termini of each putative a-helix are marked.
Regions at which chymotrypsin cleaves apoC-II in the absence of DMPC are
indicated by red arrows. The convex SDS-binding surface is shown. Blue
stars indicate the N- and C-termini of fragments 1 and 3, which are observed
to bind DMPC.
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RESULTS
Phospholipid suspensions dissociate in the
mass spectrometer
The mass spectra obtained from homogeneous preparations
of phospholipid vesicles consisting of DMPC, POPE, and
POPC are shown in Fig. 2. POPC has the same phospha-
tidylcholine headgroup as DMPC, whereas POPE has
a phosphatidylethanolamine headgroup. POPC and POPE
have the same fatty acid tails, and are monounsaturated,
whereas DMPC is fully saturated. A number of peaks are
observed in the resulting mass spectra that correspond to
different numbers of lipid molecules in complex. It is in-
teresting to note that the peaks arise from association of
lipid molecules rather than charging of a single species as
is commonly observed in electrospray mass spectra of pro-
teins. For example, for the 11 charge state between one and
six molecules of DMPC are observed, held together by
noncovalent forces in the mass spectrometer. Within the
same mass spectrum up to four charges are retained on the
complex, giving rise to an assembly consisting of up to 25
DMPC molecules. The spectra of POPE and POPC give rise
to a similar pattern of peaks, and in both spectra assemblies
of up to 23 phospholipid molecules are observed. In all cases
the monomeric lipid molecule is virtually absent, dimeric or
trimeric species predominating in each case.
For protein complexes it is generally accepted that mul-
tiple low energy collisions within the ﬂight path of the ion
absorb excess translational energy and consequently reduce
the internal energy of the ions (Rostom and Robinson, 1999).
This process, often referred to as collisional cooling, has
been shown to be effective in maintaining noncovalent
interactions in large macromolecular complexes (Krutchin-
sky et al., 1998; Sobott et al., 2002). For lipid interactions
collisional cooling gives rise to many more peaks at higher
m/z values (Fig. 3) than those observed in Fig. 2. The
increased number of peaks observed under these conditions
is due to the reduction in the internal energies of the ions,
which leads to an increase in the size of the assemblies that
can be maintained. For example, for the 111 charge state
series (Fig. 3), complexes of up to 76 lipids are observed. In
the 121 charge state, the highest charge state that can be
identiﬁed, the largest complex is assigned to 95 lipids with
a mass of 64 410 Da.
Apolipoprotein C-II phospholipid complexes
A typical positive ion nanoﬂow ESI mass spectrum of apoC-
II introduced from aqueous solution is shown (Fig. 4 A). The
charge states are well-resolved multiplets, the multiplicity
resulting from sodium ions binding to the protein. There are
also peaks that correspond to apoC-II with an additional
mass of 131 Da. These peaks are due to incomplete pro-
cessing of the protein and represent apoC-II with an N-ter-
minal methionine. The measured masses of apoC-II, 8915.3
Da, and Met-apoC-II, 9046.3 Da, are within 0.1% of the
FIGURE 2 Electrospray mass spectra of homogeneous phospholipid
suspensions formed from (A) DMPC (labeled D), (B) POPE (labeled E),
and (C) POPC (labeled P). Peaks labeled with the number of phospholipid
molecules are singly charged. For all other species the charge state of the
ions is indicated in parentheses.
FIGURE 3 Electrospray mass spectrum of phospholipid suspensions
formed from DMPC in the presence of collisional cooling of the ions. Under
these mass spectrometry conditions associations of up to 76 lipid molecules
are maintained. Only those peaks from the 111 charge state series are
labeled for clarity. It is interesting to note that when collisional cooling
is employed all peaks except those corresponding to one and two lipids are
18 m/z units higher than their calculated m/z values. This difference remains
the same over all of charge states, and is probably the result of binding of
ammonium ðNH14 Þ ions, present in the buffer, that contribute to the positive
charging of these phospholipid complexes.
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calculated masses (8915.9 Da and 9046.9 Da, respectively).
An interesting feature of the apoC-II spectrum is that the
peak corresponding to the protein binding to two sodium
ions is of higher intensity than that corresponding to the
protein with one sodium ion. For nonspeciﬁc binding of
sodium a statistical distribution of peaks would be antici-
pated. The results presented here therefore are consistent
with the protein binding preferentially to two sodium ions.
ApoC-II was investigated in the presence of homogeneous
suspensions of the phospholipids DMPC, POPE, and POPC.
A typical spectrum recorded for a solution of apoC-II with
DMPC is shown (Fig. 4 B). The spectra show some free
protein as well as lipid/lipid and protein/lipid interactions. It
is interesting to note that there is little change in the charge
state distribution of the protein when in aqueous solution and
when bound to lipid (highest intensity charge states 51 and
41, respectively). Since the phospholipid molecules used in
this study have no net charge, this suggests an ion pair
formation in the more compact lipid-bound protein. Also
present within this mass spectrum are a number of peaks
corresponding in mass to apoC-II complexed with DMPC
molecules. It can be seen that from one to six lipid molecules
remain bound to apoC-II in the 41 charge state series under
these mass spectrometry conditions.
Spectra were also recorded employing a higher degree of
collisional cooling (Fig. 4 C). Under these conditions many
more lipid/lipid interactions are maintained (up to 25 as
opposed to only two under the conditions used to record the
spectrum in Fig. 4 B). This spectrum also highlights an
interesting feature of apoC-II in complex with DMPC. In this
case the 61 charge state series is predominant for the
protein/lipid complex. Careful examination of this series
reveals complexes with three, ﬁve, and seven lipid molecules
bound to the protein. Interestingly the binding of four or six
lipid molecules is not detected. This observation was found
to be highly reproducible. In the 41 charge state series,
however, all species are represented (Fig. 4 B), the number of
lipid molecules binding to the protein increasing consecu-
tively. This is the same for all other charge states observed
for this protein/lipid complex (data not shown). For apoC-II
in the 61 charge state, however, protein/DMPC complexes
show preference for numbers of lipid molecules, a property
not observed for other charge state series.
Phospholipid vesicles composed of POPE were examined
in the presence of apoC-II using the same procedures as
described in Materials and Methods. Mass spectra of POPE
vesicles and apoC-II solutions show only the monomeric
protein. No lipid molecules, whether in complex with the
FIGURE 4 Electrospray mass spectra of apoC-II from aqueous ammonium acetate buffer (A) in the presence of DMPC vesicles (B) and in the presence of
DMPC and POPC suspensions with collisional cooling (C and D).
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protein, in complex with other lipid molecules, or in
monomeric form, could be detected (data not shown). POPE
has a small headgroup and an unsaturated fatty acid chain.
The ratio of the cross sectional area of the headgroup to that
of the tail dictates the orientation of lipid molecules within
micelles. A small headgroup/tail area ratio results in inverted
micelles in organic solvent. However, in aqueous solution
the formation of inverted micelles is unfavorable since the
hydrophobic hydrocarbon tails would be in contact with
water. Consequently in aqueous ammonim acetate, POPE
probably forms a hexagonal phase and precipitates. It is
plausible therefore that apoC-II is not able to bind to POPE
in this conﬁguration, since POPE is not suspended in so-
lution and is therefore not able to bind to apoC-II. Mass
spectra of apoC-II with phospholipid vesicles formed from
POPC, however, give rise to free protein, lipid complexes,
and a large number of peaks that correspond to protein/lipid
complexes. There are a number of differences between the
apoC-II/DMPC and apoC-II/POPC mass spectra. For apoC-
II/POPC complexes examination of the 41, 51, and 61
charge states reveals peaks corresponding to apoC-II binding
to consecutive numbers of lipid molecules. Consequently the
binding of POPC to apoC-II does not show preference for
binding discrete numbers of lipid molecules in any charge
state series. In the 61 charge state, in the presence of
collisional cooling, up to 22 lipid molecules are seen binding
to the protein (Fig. 4 D). The fact that this number is lower
than that observed under comparable conditions for the lipid
associations (up to 76, cf. Fig. 3) in the absence of the protein
suggests some disruption of lipid associations by protein
binding to the phospholipid surface.
As a control experiment to determine whether the
interactions observed in the mass spectra represent those
present in solution, or whether nonspeciﬁc complexes could
be formed during the electrospray process, a mixture of the
SH3 domain of bovine PI3 kinase and DMPC suspensions
was examined under identical solution and mass spectrom-
etry conditions as apoC-II and DMPC mixtures. SH3 is an
86-residue protein of 9638.6 Da, which does not bind to
lipid molecules. The percentages of hydrophobic and hy-
drophilic residues in the two proteins are similar (30%
and 62%, respectively for apoC-II; 27% and 55% for SH3).
Their isoelectric points are also similar (the pI of apoC-II is
4.8; that of SH3 is 4.6). Mass spectra of SH3 with DMPC
can be assigned to the free protein and complexes of lipid
molecules, but there are no peaks that correspond to
protein/lipid interactions. This demonstrates that proteins
that do not bind to phospholipids in solution do not show
binding to DMPC in mass spectra, under the same con-
ditions where apoC-II exhibits signiﬁcant binding. This
suggests that the complexes observed between protein and
lipid in the mass spectra are not simply governed by ion
pair formation or aggregation but represent speciﬁc
interactions of the lipid-binding protein with lipid mole-
cules.
Binding of lipids to peptides derived from apoC-II
To investigate the degree of exposure of different regions of
the protein in the absence and presence of lipid, proteolysis
of apoC-II was carried out using chymotrypsin. Analysis of
apoC-II in the absence of phospholipids reveals that a number
of fragments are formed rapidly in the ﬁrst 8 min of exposure
to chymotrypsin (Table 1). After 50 min many of the peaks
assigned to protein fragments have been further digested and
the intact protein cannot be detected. This rapid proteolysis
and large number of fragments is consistent with previous
reports that apoC-II has little secondary structure in the
absence of lipid or detergent (MacPhee et al., 1999). In
complex with phospholipid vesicles formed from DMPC, the
51 charge state of the protein remains clearly visible after 22
min of proteolysis and protein/lipid peaks are still observed
after 40 min (Fig. 5). This indicates that the digestion is
considerably slower than for the protein in the absence of
lipids. The number of cleavage sites is also reduced, from
four in the absence of lipid (Fig. 1) to two in the presence
of lipid, namely, tyrosine residues 53 and 63. Two series of
peaks in the mass spectra of the apoC-II/DMPC digestion do
not correspond to intact protein, protein fragment, lipid, or
protein/lipid peaks. These peaks result from association of
DMPC molecules with proteolysis fragments F1 and F3
(sequences 1–63 and 1–53 of the apoC-II sequence, re-
spectively; Fig. 1). These peaks correspond therefore to
lipid binding to a region of the protein that includes the SDS-
binding domain and the proposed lipid-binding domain.
Such binding was not detected for other fragments derived
from the protein. The protein fragments to which DMPC
binds are considerably longer than the proposed lipid-
binding helix, presumably because the lipid protects cleav-
able residues at the ends of the lipid-binding helix. Despite
the fact that protein hydrolysis is considerably slower in
the presence of lipid, digestion does still proceed. This
observation is attributed to the fact that apoC-II is an ex-
changeable protein associating reversibly with the lipid
surface, digestion being governed by its on-off rate from the
lipid surface. The results presented here therefore demon-
strate lipid binding to peptides generated from the proposed
lipid-binding domain, exposure of the C-terminal domain to
protease, and reversible interaction of the apoC-II with lipid
suspensions.
Interactions in heterogeneous lipid complexes
In a biological membrane a peripheral protein would interact
with many types of lipid, including steroids and triacylgly-
cerols, as well as different phospholipids. To mimic more
closely this situation in vitro, heterogeneous lipid suspen-
sions (1:1 molar ratio mixtures of DMPC and POPC, or
POPC and POPE) were prepared using standard protocols
(see Materials and Methods). The mass spectrum of DMPC/
POPE mixtures reveals a distribution of peaks (Fig. 6 A),
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which can be assigned to varying numbers of lipid molecules
in relatively few charge states (in this case either the 11 or
21 charge states). These spectra also reveal the distribution
of phospholipid molecules within each complex. If the
interaction between the two different lipid molecules was
random, a statistical, binomial distribution of lipids in each
of the complexes would result; thus, for two lipid molecules
in association, three peaks with relative intensities 1:2:1
would be anticipated. From Fig. 6 A it can be seen that for
two molecules in complex the peak assigned to (DMPC)2 is
of greater intensity than those assigned to DMPC1POPE1
and (POPE)2 (Table 2). As the number of lipid molecules in
the complexes increases to ﬁve, however, the distribution
approaches more closely that anticipated from statistical
incorporation (Fig. 6 B; Table 2). This would suggest that
POPE is found predominantly in larger complexes, and this
may reﬂect its reduced solubility in aqueous suspensions.
Similar observations were made for POPE/POPC interac-
tions (Fig. 6 C). By contrast the distribution of peaks in the
DMPC/POPC complexes is much closer to a statistical
distribution even for bimolecular interactions. The observa-
tion presumably reﬂects their closely similar properties in
aqueous suspensions.
When mixed with heterogeneous phospholipid prepara-
tions, apoC-II is exposed to two different phospholipid
molecules. It should be possible therefore to study whether
the protein is able to interact with different lipids si-
multaneously. To investigate the binding of apoC-II to these
heterogeneous suspensions, complexes were prepared and
spectra recorded under identical conditions to those de-
scribed above. Interestingly it was not possible to observe
protein/lipid binding interactions for the DMPC/POPC
complexes. For DMPC/POPE, however, complexes of up
to four POPE molecules binding to apoC-II are clearly
identiﬁed in the 41 and 51 charge state series (Fig. 6 D).
This is in contrast to the situation described above where
preparations containing POPE alone showed no interaction
with the protein. We conclude from these observations
therefore that in the presence of DMPC, POPE does not
precipitate, but rather is held in a conﬁguration where its
polar headgroup faces outwards toward the solvent, for
surface binding of apoC-II.
We also investigated preparations of lipids formed by
suspension in aqueous buffer but without prior dissolution
in CHCl3, since this was the method used to investigate
interactions of apoC-II in homogeneous lipid suspensions.
Interestingly the distribution of lipids within the complexes
(Fig. 7) is different from those observed in Fig. 6. For the
complex containing three lipid molecules, the distribution of
lipids is found to be different to that predicted by random
association (Table 2). Similarly, for a complex of seven lipid
molecules associating randomly the highest intensity peaks
should correspond to complexes containing either three POPE
and four POPC, or vice versa. The most intense peaks are in
fact those corresponding to sevenmolecules of either POPEor
POPC (Table 2). This deviation from statistical behavior is
consistent with a preference for the same phospholipid
molecules to associate rather than to interact with molecules
containing different headgroups or fatty acid side chains.
The mass spectra of apoC-II in complex with DMPC/
POPC and POPE/POPC prepared without prior dissolution
FIGURE 5 Chymotryptic digest of apoC-II in DMPC vesicles at t¼ 0 (A),
after 12 min (B), and after 40 min (C). (Inset) The rate of digestion calculated
from the intensity of the peaks in the mass spectra is plotted in the absence of
vesicles (circles) and in the presence of DMPC vesicles (squares). Peptide
fragments labeled F1 and F3 (see Fig. 1) bind up to two and three DMPC
molecules, respectively.
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in CHCl3 are shown in Fig. 8, A and B. As in spectra
recorded for apoC-II with homogeneous lipid preparations,
protein/lipid binding peaks are observed that correspond to
the association of increasing numbers of lipids to a single
protein molecule. In the presence of DMPC/POPC (Fig. 8 A)
charge states 41 and 51 are present, with the latter having
the highest intensity peaks for lipid binding to the protein.
This is similar to the charge states observed in spectra of
apoC-II with DMPC alone (cf. Fig. 4). Interestingly, despite
the fact that apoC-II showed no interaction with homoge-
neous POPE molecules, for mixed phospholipid samples
prepared either from CHCl3 or by direct mixing (Figs. 6 and
8 B), interactions are clearly observed with POPE.
It is also of interest to examine the distribution of lipid
molecules in these complexes. Among the factors that
determine this distribution are the tendency of identical lipids
to interact and the afﬁnity of the protein for the various lipid
molecules. For apoC-II with DMPC and POPC, the peaks at
m/z ;1400 can be assigned to the complexes (DMPC)2,
(DMPC/POPC), or (POPC)2. For a statistical association of
the lipid molecules in this bimolecular complex the ratio of
intensities of the peaks would be 1:2:1. The experimentally
determined ratio of intensities of the peaks is;1:2.8:2 (Table
2). Similarly for the analogous complexes formed between
POPE and POPC the ratio of intensities is;1:2.4:2 (Table 2),
indicating that the associations of the lipids are not random.
Close examination of the distribution of lipid molecules in
the protein/lipid complexes reveals that for DMPC/POPC,
apoC-II binding to one molecule of DMPC and one of POPC
is more intense than peaks assigned to apoC-II binding to
two molecules of the same lipid (Fig. 8 D). A similar
situation is observed for apoC-II in complex with POPE/
FIGURE 6 Electrospray mass spectra of complexes of heterogeneous lipid preparations formed from DMPC/POPE (A and B) and POPE/POPC (C) by
dissolution of the dry powders in CHCl3 and of complexes of apoC-II with heterogeneous lipid complexes formed from DMPC/POPE (D).
TABLE 1 ApoC-II fragments produced during proteolysis
using chymotrypsin
Fragment number Fragment residues Mass/Da
1 1–63 7197
2 64–79 1736
3 1–53 6169
4 54–63 1046
5 38–48 1292
6 1–37 4234
7 38–53 1953
8 1–48 5508
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POPC (Fig. 8 D). In both cases therefore the peaks of highest
intensity are assigned to protein in complex with two differ-
ent lipid molecules simultaneously. The protein/lipid assoi-
cations therefore follow a statistical distribution to a greater
degree than when the protein is absent (Table 2). Interesting-
ly the ratio of peaks assigned to the DMPC/POPC /protein
complex is closely similar to those measured for interactions
of lipid molecules alone within the same spectrum. By
contrast for POPE/POPC the ratios are different, the peak
assigned to protein binding to (POPE)2 being of higher
intensity than the analogous peak for binding to (POPC)2,
whereas for the free lipids within the same spectrum the
opposite is true. Thus the distribution of lipid molecules
differs when attached to the protein compared with when free
within the same spectrum. For the heterogeneous phospho-
lipid suspensions examined here, therefore, the distribution
of lipid molecules is not necessarily the same whether in
contact with the protein or with other phospholipids.
The second factor that is likely to play a part in the
distribution of lipid molecules in heterogeneous suspensions
is their propensity for binding to apoC-II. From Fig. 8 C it
can be seen that the peak assigned to apoC-II/ (POPC)2 is of
higher intensity than the corresponding peak for DMPC.
Similarly from Fig. 8 D it can be seen that apoC-II binding to
two molecules of POPE is of greater intensity than that
for binding to POPC. These results allow us to establish
that apoC-II binds preferentially to POPE over POPC, and
similarly that POPC binds preferentially over DMPC.
Examination of the structures of these lipids allows us to
conclude that lipids with an unsaturated side chain have
a higher afﬁnity for apoC-II than those with fully saturated
hydrocarbon chains.
DISCUSSION
Human apolipoprotein C-II has been investigated in the
presence of homogeneous and heterogeneous phospholipid
preparations. The mass spectra of homogenous lipid sus-
pensions demonstrate that complexes of large numbers of
lipid molecules can be maintained within the mass spec-
trometer. For apoC-II in the presence of phospholipid sus-
pensions the associations between protein and lipid can also
be examined. This enabled us to probe the ability of the
protein to bind to different phospholipid molecules. The
results show that the number of lipid molecules that remain in
association in the gas phase is signiﬁcantly reduced when
compared to spectra recorded for lipid suspensions in the
absence of protein. Chymotryptic digestion of apoC-II in the
presence and absence of phospholipid suspensions reveals
the exposed regions of the protein. For heterogeneous lipid
suspensions the results show a strong tendency for lipids
of identical structure to form complexes. This property is
signiﬁcantly reduced in the presence of apoC-II, when
a distribution closer to that predicted from random associaton
of lipid molecules is observed. This result is in accord with
the ﬁnding for homogeneous lipid suspensions where protein
binding to the phospholipid suspensions disrupts the lipid
packing forces, leading to signiﬁcantly reduced numbers of
interacting lipid molecules.
It is interesting to discuss whether the associations of
apoC-II with phospholipid suspensions, as well as the lipid/
TABLE 2 Distribution of peaks in lipid complexes formed under different conditions
Prep. of lipids Number of lipid molecules Statistical Experimental DMPC/POPC Experimental POPE/POPC
Experimental
DMPC/POPE
1 2 1:2:1 1:4:8:7.5:3:0 5:3:1
5 1:5:10:10:5:1 0:3:7:8:4:1
2 3 1:3:3:1 10:3.5:3:6
7 1:7:21:35:35:21:7:1 18:11:10:11:11:10:8:20
3 2 1:2:1 1:3:2 2:3:1
4 2 1:2:1 1:2.8:2 1:2.4:2
Mixtures of lipids formed after dissolution in CHCl3 (1), show a distribution closer to statistical as the size of the complex increases. From aqueous
suspensions in the absence of apoC-II (2) the distribution is far from statistical. By contrast, in the presence of apoC-II the distribution is more similar to that
predicted statistically, whether free in the spectrum (3) or bound to apoC-II (4).
FIGURE 7 Electrospray mass spectrum of heterogeneous vesicles formed
from equimolar ratios of POPE and POPC in aqueous suspensions. The
distribution of lipids in the various complexes results from a tendency of the
same lipid molecules to self-associate. (Inset) The distribution of species
resulting from the formation of a complex of seven lipid molecules is
compared with a theoretical binomial distribution assuming random
association of lipid molecules in the bilayer. The intensity of the theoretical
and experimental peaks is plotted against the m/z values of the peaks.
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lipid associations themselves, reﬂect solution phase associ-
ations. For protein complexes, the overwhelming evidence
of stoichiometry of interacting subunits identical to that
deﬁned by other techniques provides compelling evidence
that noncovalent complexes that are observed in mass
spectra under the appropriate conditions are those that exist
in solution (Sobott et al., 2002). Several lines of evidence in
this study support the proposal that the protein/lipid
associations observed here can also be related to those
occurring in solution. The ﬁrst line of evidence comes from
the fact that for lipid/lipid associations there is a tendency to
form complexes containing the same lipid molecules. The
fact that this preference is most likely a solution phase
phenomenon that is clearly preserved in mass spectra
supports the assertion that these solution phase interactions
are maintained in the gas phase. The second line of evidence
comes from proteolysis experiments with lipid binding to
peptides generated from the proposed lipid binding domain
and the absence of peaks corresponding to lipid molecules
binding to the C-terminal region. Up to three lipid molecules
are observed in complex with the peptide 1–63, whereas only
two are observed interacting with the shorter fragment 1–53
(see Fig. 1 for locations of these residues). The third
experimental evidence comes from the inability of a protein
of closely similar properties to give rise to peaks in mass
spectra that can be assigned to protein/lipid interactions. The
ﬁnal evidence in support of our assertion that these as-
sociations are derived from speciﬁc solution phase com-
plexes comes from the interactions of the protein with mixed
phospholipid suspensions. Here the favorable associations
observed for the same lipid molecules are no longer main-
tained. The binding of the protein results in disruption of
ordered suspensions such that the protein interacts with
lipid molecules in such a way that the distribution ap-
proaches that predicted statistically. Such a distribution is
also observed for lipid peaks not bound to the protein but
present in the same solution as protein/lipid complexes. The
deviations between the ratio of peaks in the lipid complexes
and the protein/lipid complexes presumably arise from local
and long range effects of protein binding to the lipid surface.
The preferred association of identical lipid molecules in the
absence of protein, lipid binding to peptides derived from the
lipid binding domain, disruption of ordered suspensions in
the presence of protein, and the failure of a protein with
FIGURE 8 Electrospray mass spectra of complexes of apoC-II with heterogeneous lipid vesicles formed from DMPC/POPC (A) and POPE/POPC (B). The
peaks assigned to protein and lipid molecules conﬁrm that apoC-II is able to bind simultaneously to both lipids. Expansion of the peaks assigned to apoC-II
bound to DMPC/POPC (C) and POPE/POPC (D) reveals that the distribution of lipid molecules in these complexes approaches a statistical distribution.
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similar characteristics to bind lipid molecules taken together
provide compelling evidence that the associations observed
in the mass spectra reﬂect, at least in part, the associations
that are occurring in solution. The question now arises as to
the extent these associations are preserved.
The approximate number of molecules in a DMPC bilayer
vesicle of radius 100 nm has been calculated as ;568,000
molecules (Hanson, 2002). These interactions are held
together principally by weak van der Waals forces. In this
study the precise nature of the lipid complexes is unknown,
but as the assemblies are transferred from solution to gas
phase the internal energy of the ions increases such that
disruption of these forces could occur, leaving only a fraction
of the associations intact (50–100 lipids, or ;1.5%). For the
complexes formed between protein and lipid up to 22 POPC
molecules are observed in complex with apoC-II in the gas
phase. The results from the chymotryptic digestion suggest
however that up to three DMPC molecules are in direct
contact with apoC-II. The interactions between protein and
the 22 lipid molecules are presumably mediated through
lipid/lipid as well as protein/lipid interactions, maintained by
weak van der Waals forces. From the evidence presented
here we propose therefore that the mass spectra recorded for
phospholipid suspensions and their complexes with apoC-II
represent a portion of the lipid assemblies rather than random
associations through aggregation of individual lipid and
protein molecules.
It is interesting to consider the ﬁndings of this study and
their implications for the binding of apoC-II to lipid
molecules. It is well established that the types of phospholipid
present inﬂuence the bending rigidity of a phospholipid
bilayer as well as the protein topology (Bogdanov et al.,
2002), and that the distribution of lipids in a bilayer inﬂuences
the folding stability of membrane proteins (Booth et al.,
1997). The phosphoethanolamine headgroup decreases bi-
layer rigidity and increases curvature stress compared to the
phosphocholine headgroup. POPE therefore increases cur-
vature stress within a bilayer relative to POPC. The ability of
apoC-II to bind POPE in mixed preparations is interesting,
because in mass spectra of apoC-II/POPE alone, no peaks
could be assigned to POPE or its complexes or to apoC-II/
POPE. This is presumably because POPE and other un-
saturated phosphatidylethanolamines have packing parame-
ters greater than 1 (Janes, 1996), which results in an inverted
cone shape and a tendency for formation of inverted micelles
in organic solvent. In aqueous solvent POPE aggregates and
precipitates, and apoC-II therefore cannot bind. Both DMPC
and POPC have packing parameters between 0.5 and 1,
a range of values known to drive the formation of bilayers.
Although the lipid suspensions studied in our system are not
homogeneous bilayers, these factors may still inﬂuence the
packing of the phospholipids in these suspensions. The
presence of POPC therefore induces POPE to bind to the
protein, because in mixed systems it precipitates. When
mixed lipid solutions are prepared using CHCl3, POPE is the
only lipid observed binding to the protein, and when CHCl3 is
not used, POPE binds to apoC-II to a greater degree than do
POPC and DMPC, suggesting that POPE interacts favorably
with apoC-II. This may reﬂect the preference of apoC-II to
associate with POPE in vivo; although the protein is not
associated with phospholipid suspensions in vivo, but rather
with lipid monolayers on lipoproteins, it may bind to lipid
surfaces with a similar degree of curvature stress to that in
POPE suspensions. The preferential binding of apoC-II to
POPE implies that, in the system studied, POPE binds as
a well-deﬁned cluster or microdomain. Microdomains in
general can be functionally important structures in vivo, for
example in the context of ‘‘lipid rafts,’’ localized regions of
elevated cholesterol and glycosphingolipid content within
cell membranes, known to be involved in cell signaling (Pike,
2003). Whether or not the microdomain formed by POPE is
physiologically relevant, our results not only provide new
insight into lipid binding interactions with apoC-II, but also
serve to demonstrate the potential for mass spectrometry to
compliment existing biophysical approaches.
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